We make a real difference to patients living with bowel cancer by funding research and working with cancer specialists to share knowledge that embed changes in practice, through workshops and conferences, thus helping more patients live well, for longer.

 

• We educate

We have trained thousands of cancer specialists including surgeons, radiologists, pathologists, oncologists and nurses – sharing lifesaving and life-enhancing knowledge and skills across the UK and worldwide. Every cancer patient in Great Britain and Ireland is discussed by a multi- disciplinary team (MDT) of relevant specialists, to make sure that all available treatment options are considered for each individual. Pelican is very proud to have played a huge role in championing MDT working with colorectal teams, as part of The English National MDT-TME Development Programme delivered between 2003-2006. Click here to view our courses.

• We support and fund research

We have invested heavily in clinical research to help save the lives of patients living with bowel cancer. When bowel cancer spreads to the liver it is called liver metastasis. Through research and education, we support advancing ways to predict which patients will develop liver metastases and development of treatment options. Mr Merv Rees OBE, one of the pioneers in this field, has contributed to much of this work.

An area of increased interest and activity is for colorectal peritoneal metastases – secondary bowel cancer in the abdomen. Pelican supports research and clinical development in this area.

Another focus is pseudomyxoma peritonei, a very rare cancer usually originating in the appendix. Started by Mr Brendan Moran and colleagues, Basingstoke and North Hampshire Hospital is one of a very small number of specialist centres in the UK to treat this rare cancer and has  subsequently become the largest centre in the world for this speciality. Click here to find out more.

“In our view, all surgeons should come and see the experts work at Pelican…. The bottom line is they’ll save lives as a result”. Professor Alex Deutsch, Chair of the Yanir Foundation for the Advancement of Colorectal Surgery